Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: An evidence synthesis approach for Scotland

Addiction

Volumn 110, Issue 8, 2015, Pages 1287-1300

  Prevost, Teresa C ^a   Presanis, Anne M ^a   Taylor, Avril ^b   Goldberg, David J ^c   Hutchinson, Sharon J ^c,d   De Angelis, Daniela ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Evidence synthesis; Hepatitis C; People who inject drugs; Prevalence

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD; COMPLICATION; EPIDEMIOLOGY; FEMALE; HEPATITIS C, CHRONIC; HUMAN; MALE; MIDDLE AGED; SCOTLAND; SEX RATIO; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; SCOTLAND; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84936985165     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12948     Document Type: Article

References (34)

1. Dore G. J., Freeman A. J., Law M., Kaldor J. M. Is severe liver disease a common outcome for people with chronic hepatitis C? J Gastroenterol Hepatol 2002; 17: 423-30.
2. Nelson P. K., Mathers B. M., Cowie B., Hagan H., Des Jarlais D., Horyniak D. et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378: 571-83.
3. Mathers B. M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S. A. et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008; 372: 1733-45.
4. Micallef J. M., Kaldor J. M., Dore G. J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepatol 2006; 13: 34-41.
5. Dore G. J., Matthews G. V., Rockstroh J. Future of hepatitis C therapy: development of direct-acting antivirals. Curr Opin HIV AIDS 2011; 6: 508-13.
6. Martin N. K., Vickerman P., Grebely J., Hellard M., Hutchinson S. J., Lima V. D. et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology 2013; 58: 1598-609.
7. Scottish Executive Health Department. Hepatitis C Action Plan for Scotland: Phase II: May 2008-March 2011. Edinburgh: Scottish Executive; 2008.
8. Welton N. J., Ades A. E. A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence. J R Stat Soc C (Appl Stat) 2005; 54: 385-404.
9. Goubar A., Ades A. E., De Angelis D., McGarrigle C. A., Mercer C. H., Tookey P. A. et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J R Stat Soc A Stat Soc 2008; 171: 541-80.
10. Ades A. E., Sutton A. J. Multiparameter evidence synthesis in epidemiology and medical decision-making: current approaches. J R Stat Soc A Stat Soc 2006; 169: 5-35.
11. Presanis A. M., De Angelis D., Spiegelhalter D. J., Seaman S., Goubar A., Ades A. E. Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence. J R Stat Soc A Stat Soc 2008; 171: 915-37.
12. Harris R. J., Ramsey M., Hope V. D., Brant L., Hickman M., Foster G. R. et al. Hepatitis C prevalence in England remains low and varies by ethnicity: an update evidence synthesis. Eur J Public Health 2012; 22: 187-92.
13. Hickman M., De Angelis D., Jones H., Harris R., Welton N., Ades A. E. Multiple parameter evidence synthesis-a potential solution for when information on drug use and harm is in conflict. Addiction 2013; 108: 1529-31.
14. Information Services Division (ISD). Drug Misuse Statistics Scotland 2009. Edinburgh: ISD; 2010.
15. Shaw L., Taylor A., Roy K. M., Cameron S. O., Burns S., Molyneaux P. et al. Establishment of a database of diagnosed HCV-infected persons in Scotland. Commun Dis Public Health 2003; 6: 305-10.
16. Overstall A. M., King R., Bird S. M., Hutchinson S. J., Hay G. Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland. Stat Med 2014; 33: 1564-79.
17. Allen E., Taylor A., Palmateer N., Hutchinson S., Rees C., Johnston L. et al. The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV and Injecting Risk Behaviours Among Injecting Drug Users Attending Needle Exchanges in Scotland, 2008/2009. Paisley: University of the West of Scotland; 2010.
18. Allen E. J., Palmateer N. E., Hutchinson S. J., Cameron S., Goldberg D. J., Taylor A. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland. Int J Drug Policy 2012; 23: 346-52.
19. Gamerman D., Lopes H. F. Markov Chain Monte Carlo: Stochastic Simulation for Bayesian Inference, 2nd edn. Abingdon: Taylor & Francis; 2006.
20. Gilks W. R., Richardson S., Spiegelhalter D. J. Markov Chain Monte Carlo in Practice. London: Chapman & Hall; 1996.
21. Lunn D., Spiegelhalter D., Thomas A., Best N. The BUGS project: evolution, critique and future directions. Stat Med 2009; 28: 3049-67.
22. McDonald S. A., Hutchinson S. J., Schnier C., McLeod A., Goldberg D. J. Estimating the number of injecting drug users in Scotland's HCV-diagnosed population using capture-recapture methods. Epidemiol Infect 2014; 142: 200-7.
23. Spiegelhalter D. J., Best N. G., Carlin B. P., van der Linde A. Bayesian measures of model complexity and fit (with discussion). J R Stat Soc B 2002; 64: 583-639.
24. Dempster A. P. The direct use of likelihood for significance testing. In: Proceedings of Conference on Foundational Questions in Statistical Inference. Department of Theoretical Statistics: University of Aarhus; 1974; p.335-52.
25. Hutchinson S. J., Bird S. M., Goldberg D. J. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology 2005; 42: 711-23.
26. McLeod A., Hutchinson S., Goldberg D. Surveillance of known hepatitis C antibody positive cases in Scotland: results to 31 December 2012. HPS Wkly Rep 2013; 47: 151-4.
27. Cornberg M., Razavi H. A., Alberti A., Bernasconi E., Buti M., Cooper C. et al. A systematic review of hepatitis C virus epidemiology in Europe. Canada and Israel. Liver Int 2011; 31: 30-60.
28. Shubin M., Virtanen M., Toikkanen S., Lyytikäinen O., Auranen K. Estimating the burden of A (H1N1) pdm09 influenza in Finland during two seasons. Epidemiol Infect 2014; 142: 964-74.
29. Presanis A. M., Pebody R. G., Paterson B. J., Tom B. D. M., Birrell P. J., Charlett A. et al. Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ 2011; 343: d5408.
30. McDonald S. A., Mohamed R., Dahlui M., Naning H., Kamarulzaman A. Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesis. BMC Infect Dis 2014; 14: 564.
31. De Angelis D., Sweeting M., Ades A. E., Hickman M., Hope V., Ramsey M. An evidence synthesis approach to estimating hepatitis C prevalence in England and Wales. Stat Methods Med Res 2009; 18: 361-79.
32. McLeod A., Weir A., Aitken C., Gunson R., Templeton K., Molyneaux P. et al. Rise in testing and diagnosis associated with Scotland's Action Plan on Hepatitis C and introduction of dried blood spot testing. J Epidemiol Community Health 2014; 68: 1182-8.
33. McAllister G., Innes H., McLeod A., Dillon J. F., Hayes P. C., Fox R. et al. Uptake of hepatitis C specialist services and treatment following diagnosis by dried blood spot in Scotland. J Clin Virol 2014; 61: 359-64.
34. Cullen B. L., Hutchinson S. J., Cameron S. O., Anderson E., Ahmed S., Spence E. et al. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention. J Public Health 2012; 34: 14-23.